For Dutta, learning to manage type 1 diabetes with SGLT-2s is like learning how to manage sick days
Incretin-based multi-agonists, such as tirzepatide and retatrutide, target two or more receptors among GLP-1, GIP, and GCGR to enhance insulin secretion, improve fat metabolism, and increase energy expenditureultimately achieving greater weight loss and metabolic improvement
Recent studies have linked Now a new study published in the journal In this study, researchers found using a mouse model that GLP-1 drugs might assist with heart attack recovery by lowering a persons risk of developing major complications that can increase a persons chances of hospital admission for heart failure or death
To create viable therapeutics, researchers had to engineer GLP-1 analogs that resist enzymatic breakdown and persist long enough to exert physiological effects
Social Service specialty General Hospital of Rosarito, Baja California